This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
VEEV Volumes Double: Will Philip Morris' E-Vapor Bet Pay Off?
by Swati Prasad
PM's VEEV shipments have more than doubled in the second quarter, with Europe driving growth and new markets showing early promise.
Can ZYN and IQOS Sustain Philip Morris' Smoke-Free Surge?
by Zacks Equity Research
IQOS and ZYN power PM's smoke-free growth in Q2, now accounting for more than 40% of revenues and gross profit.
Will Strong Pricing Power Offset Altria's Volume Declines in 2025?
by Zacks Equity Research
Altria leans on strong pricing and Marlboro's brand power to offset a drop in cigarette volumes in the second quarter.
Why Altria (MO) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Company News for Jul 31, 2025
by Zacks Equity Research
Companies in The News Are: MO, AEP, GSK, EA
Altria Q2 Earnings Beat Estimates, FY25 EPS Guidance Narrowed
by Zacks Equity Research
MO beats second-quarter estimates with strong oral tobacco gains and trims FY25 EPS outlook amid shifting tobacco market trends.
Compared to Estimates, Altria (MO) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Altria (MO) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Altria (MO) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of +5.11% and +1.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Altria's Q2 Earnings on the Deck: How to Play the Stock
by Swati Prasad
MO's Q2 results are likely to reflect NJOY ACE's market exit and soft cigarette volumes, though pricing strength may help.
MO vs. PM: Which Tobacco Stock Has More Puff Left in 2025?
by Swati Prasad
MO's pricing strength and PM's global smoke-free push show momentum. But which tobacco stock leads now?
Why Altria (MO) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Procter & Gamble Q4 Earnings Preview: What Should Investors Expect?
by Zacks Equity Research
PG targets modest Q4 and FY25 growth, banking on strong brands, pricing power and cost savings to offset FX, tariffs and China market pressure.
Here's Why Philip Morris Raises Its 2025 EPS Guidance Again
by Zacks Equity Research
PM hikes its 2025 EPS guidance as smoke-free products like IQOS and ZYN boost the second-quarter performance.
Here's Why Altria (MO) is a Strong Growth Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Exploring Analyst Estimates for Altria (MO) Q2 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Altria (MO) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Should Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPHD
Altria (MO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is on! the Bright Spot in Altria's Oral Tobacco Portfolio?
by Zacks Equity Research
With rising brand loyalty and expanding reach, on! is reshaping MO's future in the oral nicotine space.
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know
by Zacks Equity Research
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should Philip Morris Stock Be in Your Portfolio Ahead of Q2 Earnings?
by Swati Prasad
PM's second quarter results are likely to benefit from strong pricing and sustained smoke-free momentum despite currency pressures.
Keurig to Post Q2 Earnings: What Is in the Cards for Investors?
by Zacks Equity Research
KDP's Q2 results are likely to reflect benefits from strong beverage demand, GHOST acquisition gains and innovation despite coffee headwinds.
Turning Point Brands (TPB) Soars 5.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Turning Point Brands (TPB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Are Consumer Staples Stocks Lagging Altria Group (MO) This Year?
by Zacks Equity Research
Here is how Altria (MO) and Carlsberg AS (CABGY) have performed compared to their sector so far this year.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.